169 related articles for article (PubMed ID: 9385849)
1. Does schistosomiasis play a role in the high sero prevalence of HCV antibody among Egyptians?
el-Zayadi AR; Selim O; Ibrahim EH; Hamdy H; Dabbous H; Ahdy A; Moneim SA
Trop Gastroenterol; 1997; 18(3):98-100. PubMed ID: 9385849
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver disease and hepatitis C virus in Egyptian patients.
El-Medany OM; El-Din Abdel Wahab KS; Abu Shady EA; Gad El-Hak N
Hepatogastroenterology; 1999; 46(27):1895-903. PubMed ID: 10430366
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya.
Ilako FM; McLigeyo SO; Riyat MS; Lule GN; Okoth FA; Kaptich D
East Afr Med J; 1995 Jun; 72(6):362-4. PubMed ID: 7498004
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C virus among bilharziasis patients.
Khan ZA; Alkhalife IS; Fathalla SE
Saudi Med J; 2004 Feb; 25(2):204-6. PubMed ID: 14968219
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma.
Mabrouk GM
Dis Markers; 1997 Nov; 13(3):177-82. PubMed ID: 9405930
[TBL] [Abstract][Full Text] [Related]
7. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
9. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease.
Elsammak MY; Al-Sharkaweey RM; Ragab MS; Amin GA; Kandil MH
Parasite Immunol; 2008; 30(11-12):603-9. PubMed ID: 19067841
[TBL] [Abstract][Full Text] [Related]
10. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence.
Abdel-Aziz F; Habib M; Mohamed MK; Abdel-Hamid M; Gamil F; Madkour S; Mikhail NN; Thomas D; Fix AD; Strickland GT; Anwar W; Sallam I
Hepatology; 2000 Jul; 32(1):111-5. PubMed ID: 10869297
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France].
Roudot-Thoraval F; Deforges L; Girollet PP; Maria B; Milliez J; Pathier D; Duval J; Dhumeaux D
Gastroenterol Clin Biol; 1992; 16(3):255-9. PubMed ID: 1582542
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C virus antibody in the serum of blood donors].
Barna TK; Ozsvár Z; Szendrényi V; Gál G
Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis.
Taglione E; Vatteroni ML; Martini P; Galluzzo E; Lombardini F; Delle Sedie A; Bendinelli M; Pasero G; Bencivelli W; Riente L
J Rheumatol; 1999 Feb; 26(2):370-2. PubMed ID: 9972971
[TBL] [Abstract][Full Text] [Related]
16. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
Dubois F; Barin F; Goudeau A
Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
[TBL] [Abstract][Full Text] [Related]
18. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
[TBL] [Abstract][Full Text] [Related]
19. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C in Venezuela. Preliminary report].
Muller G; Zabaleta M; Caldera LH; Bianco N; Machado IV
G E N; 1990; 44(4):336-42. PubMed ID: 1967086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
